Psychology & Intimacy Johns Hopkins Researchers Uncover Promising New Avenues for Alzheimer’s Treatment Personalization Through Brain Organoid Studies July 23, 2026 Rebecca Shoemaker Scientists at Johns Hopkins Medicine have identified significant new evidence suggesting that miniature clusters of brain tissue, cultivated from the cells of individuals diagnosed with Alzheimer’s disease, hold the potential…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Experimental Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis Bacteria July 19, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a groundbreaking experimental therapeutic DNA vaccine for tuberculosis (TB), delivered non-invasively through the nose.…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis July 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant TB Bacteria, Offering New Hope Against Global Health Scourge. July 5, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
Psychology & Intimacy A New Frontier in Alzheimer’s Research: Johns Hopkins Scientists Uncover Potential of a Brain-Boosting Gas April 24, 2026 Rebecca Shoemaker Researchers at Johns Hopkins Medicine are forging a promising new path in the fight against Alzheimer’s disease, thanks to a recently awarded grant from the National Institutes of Health (NIH).…
Psychology & Intimacy A Novel Protein Pathway for Alzheimer’s Treatment Emerges from Johns Hopkins Research April 9, 2026 Rebecca Shoemaker Researchers at Johns Hopkins Medicine are at the forefront of a promising new avenue for Alzheimer’s disease treatment, thanks to a recently funded study by the National Institutes of Health…
